Susquehanna International Group
RYTM icon

Susquehanna International Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Susquehanna International Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.42M Buy
50,784
+46,687
+1,140% +$4.54M ﹤0.01% 4463
2025
Q4 		$439K Buy
4,097
+993
+32% +$105K ﹤0.01% 9111
2025
Q3 		$313K Sell
3,104
-74,158
-96% -$6.88M ﹤0.01% 10006
2025
Q2 		$4.88M Sell
77,262
-5,718
-7% -$350K ﹤0.01% 4016
2025
Q1 		$4.4M Buy
82,980
+32,316
+64% +$1.79M ﹤0.01% 3896
2024
Q4 		$2.84M Buy
50,664
+29,183
+136% +$1.61M ﹤0.01% 4585
2024
Q3 		$1.13M Sell
21,481
-2,644
-11% -$127K ﹤0.01% 6511
2024
Q2 		$991K Sell
24,125
-79,128
-77% -$3.16M ﹤0.01% 6622
2024
Q1 		$4.47M Buy
103,253
+71,021
+220% +$3.11M ﹤0.01% 3802
2023
Q4 		$1.48M Buy
32,232
+1,776
+6% +$56K ﹤0.01% 6039
2023
Q3 		$698K Buy
30,456
+14,158
+87% +$317K ﹤0.01% 7454
2023
Q2 		$269K Sell
16,298
-768,257
-98% -$13.9M ﹤0.01% 9665
2023
Q1 		$14M Buy
784,555
+90,513
+13% +$2.27M ﹤0.01% 2066
2022
Q4 		$20.2M Buy
694,042
+479,520
+224% +$12.3M 0.01% 1510
2022
Q3 		$5.26M Buy
214,522
+150,261
+234% +$2.79M ﹤0.01% 3078
2022
Q2 		$267K Buy
64,261
+46,590
+264% +$255K ﹤0.01% 9881
2022
Q1 		$204K Sell
17,671
-46,797
-73% -$411K ﹤0.01% 11190
2021
Q4 		$643K Buy
64,468
+11,265
+21% +$127K ﹤0.01% 8481
2021
Q3 		$695K Buy
53,203
+9,668
+22% +$148K ﹤0.01% 8538
2021
Q2 		$852K Sell
43,535
-80,202
-65% -$1.67M ﹤0.01% 8194
2021
Q1 		$2.63M Buy
123,737
+72,222
+140% +$2.09M ﹤0.01% 5261
2020
Q4 		$1.53M Sell
51,515
-17,751
-26% -$451K ﹤0.01% 5699
2020
Q3 		$1.5M Buy
69,266
+59,391
+601% +$1.36M ﹤0.01% 5180
2020
Q2 		$220K Sell
9,875
-5,830
-37% -$114K ﹤0.01% 8873
2020
Q1 		$239K Buy
+15,705
New +$281K ﹤0.01% 8384
2019
Q4 		– Sell
-11,782
Closed -$254K – 10496
2019
Q3 		$254K Sell
11,782
-3,148
-21% -$67.5K ﹤0.01% 8657
2019
Q2 		$328K Buy
+14,930
New +$377K ﹤0.01% 8129

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Susquehanna International Group's RYTM Position: Q1 2026 in Review

Susquehanna International Group increased its Rhythm Pharmaceuticals (RYTM) stake by 1,140% in Q1 2026, buying an estimated $4.54M and bringing the position to 50,784 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4463.

Susquehanna International Group first reported a position in RYTM in Q2 2019 and has held it in 27 quarters since. The position peaked at $20.2M in Q4 2022. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Susquehanna International Group held 50,784 shares of Rhythm Pharmaceuticals worth $4.42M as of Q1 2026.
  • Susquehanna International Group bought 46,687 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $4.54M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4463 holding.
  • Susquehanna International Group first reported a position in Rhythm Pharmaceuticals in Q2 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Rhythm Pharmaceuticals position peaked at $20.2M in Q4 2022.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.